metformin has been researched along with Growth Hormone Insensitivity Syndrome in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Excerpt | Relevance | Reference |
---|---|---|
"His parents both had a diagnosis of type 2 diabetes." | 1.39 | Diabetes mellitus with Laron syndrome: case report. ( Agladıoglu, SY; Aycan, Z; Bas, VN; Cetınkaya, S; Kendırcı, HN; Onder, A; Savas Erdeve, S, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agladıoglu, SY | 1 |
Cetınkaya, S | 1 |
Savas Erdeve, S | 1 |
Onder, A | 1 |
Kendırcı, HN | 1 |
Bas, VN | 1 |
Aycan, Z | 1 |
1 other study available for metformin and Growth Hormone Insensitivity Syndrome
Article | Year |
---|---|
Diabetes mellitus with Laron syndrome: case report.
Topics: Adult; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Monitoring; Humans; Hypoglycemic Agen | 2013 |